Local Amplification of Glucocorticoids by 11β‐Hydroxysteroid Dehydrogenase Type 1 and Its Role in the Inflammatory Response
- 1 November 2006
- journal article
- review article
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 1088 (1) , 265-273
Abstract
Abstract: Glucocorticoids are widely used to treat chronic inflammatory conditions including rheumatoid arthritis. They promote mechanisms important for normal resolution of inflammation, notably macrophage phagocytosis of leukocytes undergoing apoptosis. Prereceptor metabolism of glucocorticoids by 11β‐hydroxysteroid dehydrogenase type 1 (11β‐HSD1) amplifies intracellular levels of glucocorticoids by oxoreduction of intrinsically inert cortisone (in humans, 11‐dehydrocorticosterone in mice) into active cortisol (corticosterone in mice) within cells expressing the enzyme. Recently, we have shown in a mouse model of acute inflammation, high expression of 11β‐HSD oxoreductase but not dehydrogenase activity in cells elicited rapidly in the peritoneum by a single thioglycollate injection. 11β‐HSD oxoreductase activity remained high in peritoneal cells until the inflammation resolved. In vitro, the 11β‐HSD1 substrate, 11‐dehydrocorticosterone, increased macrophage phagocytosis of apoptotic neutrophils to the same extent as corticosterone. This effect was dependent upon 11β‐HSD1: these cells solely expressed the type 1 11β‐HSD isozyme (not 11β‐HSD2), and carbenoxolone, an 11β‐HSD inhibitor, prevented the increase in phagocytosis elicited by 11‐dehydrocorticosterone. Macrophages from 11β‐HSD1‐deficient mice failed to respond to 11‐dehydrocorticosterone. In vivo, 11β‐HSD1‐deficient mice showed a delay in acquisition of macrophage phagocytic competence and had an increased number of free apoptotic neutrophils during sterile peritonitis. Importantly, in preliminary experiments, 11β‐HSD1‐deficient mice exhibited delayed resolution of inflammation in experimental arthritis. These findings suggest 11β‐HSD1 may be a component of mechanisms engaged early during the inflammatory response that promote its subsequent resolution.Keywords
This publication has 57 references indexed in Scilit:
- Expression of 11β-hydroxysteroid dehydrogenase type 1 permits regulation of glucocorticoid bioavailability by human dendritic cellsBlood, 2005
- Hexose‐6‐phosphate dehydrogenase determines the reaction direction of 11β‐hydroxysteroid dehydrogenase type 1 as an oxoreductaseFEBS Letters, 2004
- Tissue-Specific Glucocorticoid Reactivating Enzyme, 11β-Hydroxysteoid Dehydrogenase Type 1 (11β-HSD1) - A Promising Drug Target for the Treatment of Metabolic SyndromeCurrent Drug Target - Immune, Endocrine & Metabolic Disorders, 2003
- Preadipocyte Conversion to MacrophageJournal of Biological Chemistry, 2003
- Molecular Control of Immune/Inflammatory Responses: Interactions Between Nuclear Factor- B and Steroid Receptor-Signaling PathwaysEndocrine Reviews, 1999
- Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF.Journal of Clinical Investigation, 1998
- Tumor Necrosis Factor α and Interleukin 1β Enhance the Cortisone/Cortisol ShuttleJournal of Experimental Medicine, 1997
- Genetic variation in the stress response: susceptibility to experimental allergic encephalomyelitis and implications for human inflammatory diseaseImmunology Today, 1991
- Macrophage phagocytosis of aging neutrophils in inflammation. Programmed cell death in the neutrophil leads to its recognition by macrophages.Journal of Clinical Investigation, 1989
- Adrenalectomy sensitizes mice to the lethal effects of interleukin 1 and tumor necrosis factor.Journal of Experimental Medicine, 1988